Health Care
Health Care
Sally C. Pipes Discuss Obamacare Supreme Court Hearing on the Kim Monson Show
Sally C. Pipes joined the Kim Monson Show to discusses the pending U.S. Supreme Court hearing for Obamacare. Pipes explains that we are still a year or more way from a final decision, with hearings scheduled for the fall and a final decision expected 2021. Pipes and Monson also discuss ...
Sally C. Pipes
July 9, 2020
Business & Economics
Wayne Winegarden – Empowering Entrepreneurs to Address America’s Health Care Challenges
PRI Senior Fellow in Business and Economics Dr. Wayne Winegarden joins us to discuss the latest study in the “Breaking Down Barriers to Opportunity” series, which makes the case that future medical innovation will be hindered unless state and federal policymakers embrace health care entrepreneurship.
Pacific Research Institute
July 6, 2020
Coronavirus
Dr. Henry Miller and John Batchelor Review FDA COVID-19 Guidelines
PRI’s Dr. Henry Miller joins the John Batchelor Show to review the latest developments with the vaccine guidelines and the FDA. The FDA testified before Congress that they will have complicated guidelines for a potential COVID-19 vaccine. Miller mentioned that the FDA guidelines are reassuring as it indicates that future ...
Henry Miller, M.S., M.D.
July 6, 2020
Commentary
Coronavirus drug cost – Ignore critics. Here’s why the price is right
Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir’s price as soon as it was announced. They claim that Gilead could sell the drug ...
Sally C. Pipes
July 6, 2020
Commentary
Democrats Remain Jealous Of Britain’s Healthcare Catastrophe
If there was ever any doubt about the dangers of single-payer health care, the United Kingdom’s experience with COVID-19 should settle the matter. Weeks after the pandemic’s peak, the nation’s government-run health system, the National Health Service, is still subjecting patients to life-threatening treatment delays. By the NHS’s own admission, ...
Sally C. Pipes
July 6, 2020
Commentary
We must relax restrictions on foreign doctors
The Trump administration just made it a bit easier for foreign doctors to join the fight against the coronavirus. This month, U.S. Citizenship and Immigration Services authorized foreign doctors in the Conrad 30 program to conduct telehealth visits across state lines. Previously, these doctors — up to 30 per state ...
Sally C. Pipes
July 1, 2020
Commentary
Learning The Right Lessons From The Race For An Effective Covid-19 Treatment
On June 29, 2020 Gilead announced its price for remdesivir – an antiviral medication that has shown efficacy shortening the recovery time for patients with Covid-19. This price announcement provides several important lessons for the U.S. healthcare system. First, and perhaps most important, innovation is essential for winning the war against Covid-19. ...
Wayne Winegarden
June 30, 2020
Commentary
The coronavirus’s silent dental epidemic
By: Henry Miller, M.S., M.D., and Shiv Sharma, DDS As the nation slowly emerges from lockdown, we’re beginning to appreciate the full impact of the pandemic and that the sickness and death directly caused by the virus are only part of the picture. The three-month-plus suspension of routine, non-emergency medical ...
Pacific Research Institute
June 30, 2020
Commentary
Do coronavirus numbers show bias in health care? This study’s results will surprise you
African-Americans make up 12.4 percent of the population but have accounted for 23.8 percent of the nation’s COVID-19 deaths, as of June 23. This disparity has gained considerable attention in light of the protests sweeping the country. But the situation is more complicated than it appears. According to a working ...
Sally C. Pipes
June 30, 2020
Commentary
Trump not giving up on Obamacare repeal
After a decade-plus of disappointment, the end of Obamacare may finally come next year. The Trump administration recently filed a legal brief in support of the 18 states petitioning the U.S. Supreme Court to overturn Obamacare. The action has drawn sharp criticism, most notably from presumptive Democratic presidential nominee Joe ...
Sally C. Pipes
June 30, 2020
Sally C. Pipes Discuss Obamacare Supreme Court Hearing on the Kim Monson Show
Sally C. Pipes joined the Kim Monson Show to discusses the pending U.S. Supreme Court hearing for Obamacare. Pipes explains that we are still a year or more way from a final decision, with hearings scheduled for the fall and a final decision expected 2021. Pipes and Monson also discuss ...
Wayne Winegarden – Empowering Entrepreneurs to Address America’s Health Care Challenges
PRI Senior Fellow in Business and Economics Dr. Wayne Winegarden joins us to discuss the latest study in the “Breaking Down Barriers to Opportunity” series, which makes the case that future medical innovation will be hindered unless state and federal policymakers embrace health care entrepreneurship.
Dr. Henry Miller and John Batchelor Review FDA COVID-19 Guidelines
PRI’s Dr. Henry Miller joins the John Batchelor Show to review the latest developments with the vaccine guidelines and the FDA. The FDA testified before Congress that they will have complicated guidelines for a potential COVID-19 vaccine. Miller mentioned that the FDA guidelines are reassuring as it indicates that future ...
Coronavirus drug cost – Ignore critics. Here’s why the price is right
Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir’s price as soon as it was announced. They claim that Gilead could sell the drug ...
Democrats Remain Jealous Of Britain’s Healthcare Catastrophe
If there was ever any doubt about the dangers of single-payer health care, the United Kingdom’s experience with COVID-19 should settle the matter. Weeks after the pandemic’s peak, the nation’s government-run health system, the National Health Service, is still subjecting patients to life-threatening treatment delays. By the NHS’s own admission, ...
We must relax restrictions on foreign doctors
The Trump administration just made it a bit easier for foreign doctors to join the fight against the coronavirus. This month, U.S. Citizenship and Immigration Services authorized foreign doctors in the Conrad 30 program to conduct telehealth visits across state lines. Previously, these doctors — up to 30 per state ...
Learning The Right Lessons From The Race For An Effective Covid-19 Treatment
On June 29, 2020 Gilead announced its price for remdesivir – an antiviral medication that has shown efficacy shortening the recovery time for patients with Covid-19. This price announcement provides several important lessons for the U.S. healthcare system. First, and perhaps most important, innovation is essential for winning the war against Covid-19. ...
The coronavirus’s silent dental epidemic
By: Henry Miller, M.S., M.D., and Shiv Sharma, DDS As the nation slowly emerges from lockdown, we’re beginning to appreciate the full impact of the pandemic and that the sickness and death directly caused by the virus are only part of the picture. The three-month-plus suspension of routine, non-emergency medical ...
Do coronavirus numbers show bias in health care? This study’s results will surprise you
African-Americans make up 12.4 percent of the population but have accounted for 23.8 percent of the nation’s COVID-19 deaths, as of June 23. This disparity has gained considerable attention in light of the protests sweeping the country. But the situation is more complicated than it appears. According to a working ...
Trump not giving up on Obamacare repeal
After a decade-plus of disappointment, the end of Obamacare may finally come next year. The Trump administration recently filed a legal brief in support of the 18 states petitioning the U.S. Supreme Court to overturn Obamacare. The action has drawn sharp criticism, most notably from presumptive Democratic presidential nominee Joe ...